Title of article
Helicobacter pylori and Migraine: Is Eradication of Helicobacter pylori Effective in Relief of Migraine Headache?
Author/Authors
Seyyedmajidi، Mohammadreza نويسنده Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran Seyyedmajidi, Mohammadreza , Banikarim، Seyed-Amir نويسنده Golestan Research Center of Gastroenterology and Hepatology-GRCGH, Golestan University of Medical Sciences, Gorgan, Iran , , Ardalan، Afsaneh نويسنده Golestan Research Center of Gastroenterology and Hepatology-GRCGH, Golestan University of Medical Sciences, Gorgan, Iran , , Hozhabrossadati ، Seyed-Hossein نويسنده Golestan Research Center of Gastroenterology and Hepatology-GRCGH, Golestan University of Medical Sciences, Gorgan, Iran , , Norouzi، Alireza نويسنده Golestan Research Center of Gastroenterology and Hepatology-GRCGH, Golestan University of Medical Sciences, Gorgan, Iran , , Vafaeimanesh، Jamshid نويسنده Internist, Clinical Research Development Center, Qom University of Medical Sciences, Qom, Iran Vafaeimanesh, Jamshid
Issue Information
فصلنامه با شماره پیاپی 4 سال 2016
Pages
7
From page
29
To page
35
Abstract
Background: Association between Helicobacter pylori (HP) infection and migraine and the effect of HP eradication on relief of migraine headache have been studied but the results are controversial. Objectives: To evaluate the effect of HP eradication in treatment of patients affected by migraine. Materials and Methods: Eighty consecutive HP infected patients affected by migraine without aura were enrolled in this clinical trial. They have referred to an endoscopy clinic for work-up of HP infection from October 2013 to November 2014. Patients were randomly assigned in 2 groups using 2 different regimens; Group A: migraine treatment and a 14-day triple therapy for HP infection and Group B: migraine treatment without HP eradication. The mean duration (hour), headache severity (MIDAS) and the frequency (per month) of clinical headache attacks were calculated upon enrollment in the study and at 6 months and 12 months after treatment. All data were analyzed using SPSS version 16. Comparison of categorical variables across the groups was performed using Chi-square test. Results: In group A, HP infection was eradicated in 34 of 40 patients (85%). After treatment in eradicated patients compared with the control group there was significant decrease in severity and frequency (but not in duration) of the migraine attacks at 6 months (p < 0.001) and significant decrease in intensity, frequency and duration of the migraine attacks at 12 months (p < 0.001). Conclusion: HP should be considered and examined in migranous patients and eradication treatment can be beneficial for relief of clinical attacks.
Journal title
Caspian Journal of Neurological Sciences
Serial Year
2016
Journal title
Caspian Journal of Neurological Sciences
Record number
2391404
Link To Document